Phensuximide
An anticonvulsant medication
| Phensuximide | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Phensuximide is a medication used primarily in the treatment of epilepsy, specifically for absence seizures. It belongs to the class of succinimides, which are known for their effectiveness in managing certain types of seizures.
Pharmacology
Phensuximide works by reducing abnormal electrical activity in the brain. It is believed to modulate the activity of calcium channels in the thalamus, a region of the brain that plays a key role in the generation of absence seizures. By stabilizing the neuronal activity, phensuximide helps to prevent the occurrence of seizures.
Medical Uses
Phensuximide is primarily indicated for the control of absence seizures, also known as petit mal seizures. These seizures are characterized by brief, sudden lapses in attention and activity, often without any warning. Phensuximide is typically used when other medications, such as ethosuximide, are not effective or cause unacceptable side effects.
Side Effects
Common side effects of phensuximide include gastrointestinal disturbances such as nausea and vomiting, as well as drowsiness and dizziness. In some cases, it may cause more serious side effects, including blood dyscrasias and liver toxicity. Patients taking phensuximide should be monitored regularly for any adverse effects.
Mechanism of Action

Phensuximide's mechanism of action involves the inhibition of T-type calcium channels in the thalamic neurons. This inhibition reduces the pacemaker current that is responsible for generating the rhythmic cortical discharge associated with absence seizures. By dampening this activity, phensuximide helps to prevent the occurrence of seizures.
History
Phensuximide was developed as part of a series of succinimide derivatives aimed at improving the treatment of absence seizures. It was introduced as an alternative to other anticonvulsants with the goal of providing effective seizure control with fewer side effects.
Related Compounds
Phensuximide is chemically related to other succinimide anticonvulsants, such as ethosuximide and methsuximide. These compounds share a similar mechanism of action and are used in the treatment of absence seizures.
Related Pages
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian